Acute Kidney Injury Prevention

Area of Science:

• Nephrology
• Critical Care Medicine

Background:

• Acute kidney injury (AKI) presents a significant clinical challenge, marked by increasing incidence due to factors like sepsis, nephrotoxins, and hypotension.
• AKI is associated with substantial morbidity and mortality, necessitating improved risk assessment and preventive strategies.

Purpose of the Study:

• To review risk stratification for patients susceptible to AKI, particularly when the insult timing is known (e.g., cardiac surgery, contrast exposure).
• To examine preventive measures and pharmacological agents for AKI, highlighting challenges in clinical trial design and interpretation.

Main Methods:

• Literature review focusing on risk stratification, clinical contexts intensifying AKI risk, and preventive strategies.
• Analysis of clinical trials for pharmacological AKI prevention, evaluating preclinical promise versus clinical outcomes.

Main Results:

• Many pharmacological compounds show promise in preclinical AKI studies but have yielded inconsistent results in clinical trials.
• Challenges in AKI prevention trials include the need for large, well-designed studies and the identification of effective therapeutic targets.

Conclusions:

• Improving AKI prevention requires well-designed clinical trials, novel biomarkers, and innovative therapeutic strategies.
• Advancements in research are crucial for enhancing patient outcomes and reducing the burden of AKI.